ALTO-100 for Depression: Study Comparing Efficacy to Placebo

Study Description

The ALTO-100 study aims to investigate the effectiveness of using ALTO-100 as monotherapy or an adjunctive treatment alongside antidepressant medication. The study compares its efficacy with a placebo, taking patient characteristics into account.

Study Details

Registry ID:

NCT05712187

Conditions:

Major Depressive Disorder

Phase:

Phase 2

Target Enrollment:

301 participants

Start Date:

January 10, 2023

Healthy Volunteers:

No

Study Locations (35 sites)

• Site 184
  Brooklyn, New YorkUnited States, United States
• Site 210
  New York, New YorkUnited States, United States
• Site 180
  New York, New YorkUnited States, United States
• Site 151
  Baltimore, MarylandUnited States, United States
• Site 205
  Orlando, FloridaUnited States, United States
• Site 157
  North Charleston, South CarolinaUnited States, United States
• Site 213
  Tampa, FloridaUnited States, United States
• Site 212
  Tampa, FloridaUnited States, United States
• Site 204
  Jacksonville, FloridaUnited States, United States
• Site 186
  Brooksville, FloridaUnited States, United States
• Site 175
  Westlake, OhioUnited States, United States
• Site 174
  Birmingham, AlabamaUnited States, United States
• Site 173
  Huntsville, AlabamaUnited States, United States
• Site 137
  Carmel, IndianaUnited States, United States
• Site 171
  Jackson, MississippiUnited States, United States
• Site 108
  Jackson, MississippiUnited States, United States
• Site 183
  Memphis, TennesseeUnited States, United States
• Site 139
  Little Rock, ArkansasUnited States, United States
• Site 172
  Houston, TexasUnited States, United States
• Site 120
  Houston, TexasUnited States, United States
• Site 147
  Fort Worth, TexasUnited States, United States
• Site 142
  Lincoln, NebraskaUnited States, United States
• Site 185
  Centennial, ColoradoUnited States, United States
• Site 178
  Albuquerque, New MexicoUnited States, United States
• Site 136
  Chandler, ArizonaUnited States, United States
• Site 121
  Draper, UtahUnited States, United States
• Site 121a
  Murray, UtahUnited States, United States
• Site 181
  Imperial, CaliforniaUnited States, United States
• Site 144
  Las Vegas, NevadaUnited States, United States
• Site 188
  Oceanside, CaliforniaUnited States, United States
• Site 182
  Oceanside, CaliforniaUnited States, United States
• Site 179
  Rancho Cucamonga, CaliforniaUnited States, United States
• Site 141
  Costa Mesa, CaliforniaUnited States, United States
• Site 118
  Fresno, CaliforniaUnited States, United States
• Site 116
  Sacramento, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →